Consistent with other studies [21,22,24,32,33,34], it was previously shown that serum kallistatin levels correlate with glucose homeostasis, markers of chronic inflammation, and lipoprotein metabolism in both T2DM and nondiabetic obese patients [29]. Here, SERPINA4 is linked to type 2 diabetes mellitus.